As Id1−/− mice have well-documented tumour angiogenic defects and abnormal tumour growth27, we performed daily injections of B16F10 melanoma TCM and control media over 21 days to systemically supply an equal amount of tumour-derived factors in both Id1−/− and WT control mice. This evidence concerns the gene ID1 and melanoma.